Cost-minimization analysis for Portugal of five doublet chemotherapy regimens from two phase III trials in the treatment of advanced non-small cell lung cancer.

Pimentel, F L; Bhalla, S; Laranjeira, L; Guerreiro, M

Pimentel, F L; Bhalla, S; Laranjeira, L; Guerreiro, M.

Affiliation

Pimentel FL; Hospital São Sebastião, Oncology Department, R. Dr. Cândido Pinho, 4520-211 Santa Maria da Feira, Portugal. fpimentel@cs.ua.pt

Lung Cancer ; 52(3): 365-71, 2006 Jun.

Article in En | MEDLINE | ID: mdl-16650499

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/economics; Carcinoma, Non-Small-Cell Lung/economics; Lung Neoplasms/economics; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carboplatin/administration & dosage; Carboplatin/economics; Carcinoma, Non-Small-Cell Lung/drug therapy; Cisplatin/administration & dosage; Cisplatin/economics; Clinical Trials, Phase III as Topic; Costs and Cost Analysis; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Deoxycytidine/economics; Docetaxel; Female; Humans; Lung Neoplasms/drug therapy; Male; National Health Programs/economics; Paclitaxel/administration & dosage; Paclitaxel/economics; Portugal; Taxoids/administration & dosage; Taxoids/economics; Gemcitabine

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Health_economic_evaluation Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links